3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Myelodysplastic Syndromes
3
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Leukemia, Myeloid, Acute
2
Hodgkin Disease
2
Recurrence
1
Neoplasms
1
Myelodysplastic-Myeloproliferative Diseases
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Biphenotypic, Acute
1
Leukemia
1
Graft vs Host Disease
1
Burkitt Lymphoma
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
Cytarabine
3
Mitoxantrone
2
Cladribine
2
venetoclax
1
pegylated granulocyte colony-stimulating factor
1
Sorafenib
1
Razoxane
1
Leyk
1
Idarubicin
1
Gemtuzumab
1
Etoposide
1
Dexrazoxane
1
Daunorubicin
1
Bortezomib
1
Asparaginase
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma, Myeloid
×
Clofarabine
×
90 days
×
Clear all
No trials found.